Advances in the Pharmacological Management of Huntingtonʼs Disease
about
The importance of integrating basic and clinical research toward the development of new therapies for Huntington diseaseTreatment of Huntington's disease.Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease.Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease.Extracts of adipose derived stem cells slows progression in the R6/2 model of Huntington's diseaseRegulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.Synthesis of (±)-Tetrabenazine by Visible Light Photoredox CatalysisPizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's DiseaseDiffusion weighted imaging of prefrontal cortex in prodromal Huntington's disease.Localization and expression of VMAT2 aross mammalian species: a translational guide for its visualization and targeting in health and disease.Chorea associated with Huntington's disease: to treat or not to treat?Current therapeutic options for Huntington's disease: good clinical practice versus evidence-based approaches?MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?Tetrabenazine: for chorea associated with Huntington's disease.Treatment options for chorea.
P2860
Q22306292-B948B02C-CEDF-4669-9713-B8D94C13801FQ26782004-95C5EC33-CB2E-470D-8234-813F55E62E9CQ34184185-15210640-4FDD-4BB4-9FEB-472DD0780167Q34547558-4E009C44-0A3A-4325-B424-CDFFE35E4BD6Q34657923-D458E92C-9803-4ABB-8F93-E6392E029814Q34673305-ABCBC688-C239-4E49-9A42-721D13C08E11Q36386171-B2BF88DD-2928-43CE-A633-F1A450AA0F86Q36588268-2A0D40E2-55F4-4F47-9424-162A0D5D363DQ37179508-D51B7202-1157-4F44-96F6-2E841544EFE4Q37591449-0F95B17D-DBCB-4472-ABDA-5B687E42A20BQ38243296-6AD1786B-0AD8-488F-B532-753B2778D763Q38244078-A0639423-E86C-438A-90D3-D8F3C9EF647EQ38843644-6984805F-3A08-4E3C-B09B-1AE8C8AD4B9DQ45305375-30B68F66-4AA3-47EE-B1D6-A48514EF15D4Q47977953-492BC14F-D0BF-4739-83C2-D1B403E3B5A9
P2860
Advances in the Pharmacological Management of Huntingtonʼs Disease
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Advances in the Pharmacological Management of Huntingtonʼs Disease
@ast
Advances in the Pharmacological Management of Huntingtonʼs Disease
@en
Advances in the Pharmacological Management of Huntingtonʼs Disease
@en-gb
Advances in the Pharmacological Management of Huntingtonʼs Disease
@nl
type
label
Advances in the Pharmacological Management of Huntingtonʼs Disease
@ast
Advances in the Pharmacological Management of Huntingtonʼs Disease
@en
Advances in the Pharmacological Management of Huntingtonʼs Disease
@en-gb
Advances in the Pharmacological Management of Huntingtonʼs Disease
@nl
altLabel
Advances in the pharmacological management of Huntington's disease
@en
prefLabel
Advances in the Pharmacological Management of Huntingtonʼs Disease
@ast
Advances in the Pharmacological Management of Huntingtonʼs Disease
@en
Advances in the Pharmacological Management of Huntingtonʼs Disease
@en-gb
Advances in the Pharmacological Management of Huntingtonʼs Disease
@nl
P2860
P1433
P1476
Advances in the Pharmacological Management of Huntingtonʼs Disease
@en
P2093
Samuel Frank
P2860
P304
P356
10.2165/11534430-000000000-00000
P407
P577
2010-03-01T00:00:00Z
P6179
1039148462